Lista de obras -

A Comparison of Metabolic Outcomes Between Obese HIV-Exposed Uninfected Youth From the PHACS SMARTT Study and HIV-Unexposed Youth From the NHANES Study in the United States

artículo científico publicado en 2019

A Novel STAT1 Mutation Associated with Disseminated Mycobacterial Disease ⬇️

artículo científico publicado el 29 de febrero de 2012

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

artículo científico publicado en 2016

Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

artículo científico publicado en 2011

Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children

artículo científico publicado en 2002

Correlation of HIV-Specific Immunity, Viral Control, and Diversification following Planned Multiple Exposures to Autologous HIV in a Pediatric Population ⬇️

artículo científico publicado el 3 de agosto de 2011

Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial

artículo científico publicado en 2017

Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines

article

Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation

artículo científico publicado en 2016

HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission

artículo científico publicado en 2014

HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers

artículo científico publicado en 2006

HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine

artículo científico publicado en 2017

Health Outcomes of International HIV-infected Adoptees in the US.

artículo científico publicado en 2015

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine

artículo científico publicado en 2001

Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants

artículo científico publicado en 2014

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses

artículo científico publicado en 2014

Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy

artículo científico publicado en 2009

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children

artículo científico publicado en 2018

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

artículo científico publicado en 2020

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children

artículo científico publicado en 2018

Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated

scientific article published on 06 May 2019

Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children

artículo científico publicado en 2020

Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children

artículo científico publicado en 2020

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study

artículo científico publicado en 2003

Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

article

Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

artículo científico publicado en 2016

Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.

artículo científico publicado en 2011

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

scientific article published on 31 August 2020

Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization

artículo científico publicado en 2009

Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected children

artículo científico publicado en 2003

Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia

artículo científico publicado en 2008

Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection

artículo científico publicado en 2015

Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment

artículo científico publicado en 2013

Resistance to antiretrovirals in HIV-infected pregnant women

artículo científico publicado en 2009

Retention of HIV-Infected Children in the First 12 Months of Anti-Retroviral Therapy and Predictors of Attrition in Resource Limited Settings: A Systematic Review.

artículo científico publicado en 2016

Safety and Tolerability of Antiretrovirals during Pregnancy ⬇️

artículo científico publicado el 11 de abril de 2011

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women

artículo científico publicado en 2005

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women

artículo científico publicado en 2001

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

artículo científico publicado en 2019

Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review

artículo científico publicado en 2015

Short communication: The relationship between mitochondrial dysfunction and insulin resistance in HIV-infected children receiving antiretroviral therapy.

artículo científico publicado en 2013

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia

artículo científico publicado en 2008

The interaction between equipoise and logistics in clinical trials: A case study

artículo científico publicado en 2017

Vaccines for prevention of mother-to-child transmission of HIV.

artículo científico publicado en 2008

Visual Diagnosis: 19-year-old Boy with Syncope and Bradycardia

artículo científico publicado en 2016

Lista de obras de

A Comparison of Metabolic Outcomes Between Obese HIV-Exposed Uninfected Youth From the PHACS SMARTT Study and HIV-Unexposed Youth From the NHANES Study in the United States

A Novel STAT1 Mutation Associated with Disseminated Mycobacterial Disease ⬇️

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children

Correlation of HIV-Specific Immunity, Viral Control, and Diversification following Planned Multiple Exposures to Autologous HIV in a Pediatric Population ⬇️

Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial

Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines

Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation

HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission

HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers

HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine

Health Outcomes of International HIV-infected Adoptees in the US.

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine

Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses

Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children

Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated

Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children

Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study

Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization

Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected children

Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia

Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection

Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment

Resistance to antiretrovirals in HIV-infected pregnant women

Retention of HIV-Infected Children in the First 12 Months of Anti-Retroviral Therapy and Predictors of Attrition in Resource Limited Settings: A Systematic Review.

Safety and Tolerability of Antiretrovirals during Pregnancy ⬇️

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review

Short communication: The relationship between mitochondrial dysfunction and insulin resistance in HIV-infected children receiving antiretroviral therapy.

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia

The interaction between equipoise and logistics in clinical trials: A case study

Vaccines for prevention of mother-to-child transmission of HIV.

Visual Diagnosis: 19-year-old Boy with Syncope and Bradycardia